Vishal Chudiwale

Vishal Chudiwale is a seasoned professional in regulatory affairs, currently serving as the Director Global Regulatory Affairs CMC Lead Biosimilars at Fresenius Kabi since June 2025, focusing on advancing innovative treatments. Prior to this role, Vishal held the position of Head (Director) Global Regulatory Sciences - CMC at Bristol Myers Squibb, where leadership contributed to the establishment of the Global Capability Centre and mentorship of a skilled team. Experience at Novartis encompassed roles as Associate Director and Senior Manager in Regulatory CMC for biologics, with contributions to global regulatory strategies and knowledge integration initiatives. Earlier career roles included positions at Sun Pharmaceutical Industries Ltd and Torrent Pharmaceuticals Ltd, focusing on regulatory submissions and analytical method development. Vishal holds an MBA in General Management from Indian School of Business and an M.Pharm in Pharmaceutical Chemistry from Manipal Academy of Higher Education.